[Aminoglycosides to critically ill patients].
Heslet
Lars
L
H:S Rigshospitalet, ITA 4131. LarsRH03631heslet@rh.dk
Tvede
Michael
M
Schierbeck
Jens
J
D000617:Aminoglycosides / Q000008:administration & dosage / Q000627:therapeutic use*; D016638:Critical Illness; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D006801:Humans; D007769:Lactams / Q000008:administration & dosage / Q000627:therapeutic use*; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000382:microbiology / Q000401:mortality; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D018805:Sepsis / Q000188:drug therapy* / Q000382:microbiology / Q000401:mortality
D000617:Aminoglycosides; D007769:Lactams